Hansjurgen Agostini
Overview
Explore the profile of Hansjurgen Agostini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1006
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laich Y, Lang S, Glatz A, Farassat N, Bucher F, Nuessle S, et al.
Klin Monbl Augenheilkd
. 2025 Feb;
PMID: 39929207
Background: To characterize different growth patterns of retinal hemangioblastomas (RHs) in patients with von Hippel-Lindau disease (VHLD) using swept-source optical coherence tomography angiography (SS-OCTA). Methods: Single-center observational cross-sectional study. SS-OCTA...
2.
Gabel-Pfisterer A, Lang S, Boehringer D, Agostini H, de Geus L, de Faber J
Graefes Arch Clin Exp Ophthalmol
. 2024 Dec;
PMID: 39627464
Background: After 2 years of pandemic sales ban, on New Year`s Eve 2022/23 consumer firework articles were officially available again in Germany and the Netherlands. Methods: In the Netherlands we...
3.
Boneva S, Wolf J, Jung M, Prinz G, Chui T, Jauch J, et al.
J Neuroinflammation
. 2024 Nov;
21(1):297.
PMID: 39543723
Background: Despite great advances in proliferative diabetic retinopathy (PDR) therapy over the last decades, one third of treated patients continue to lose vision. While resident vitreous macrophages called hyalocytes have...
4.
Lang S, Bohringer D, Agostini H, Kuklinski M, Reinhard T, Sturm A, et al.
Klin Monbl Augenheilkd
. 2024 Oct;
241(10):1145-1155.
PMID: 39384215
Background: Eye injuries range from minor to severe and may lead to permanent visual impairment. There is still little in the way of epidemiological data on eye injuries in Germany....
5.
Liang P, Ness J, Rapp J, Boneva S, Schwammle M, Jung M, et al.
J Neuroinflammation
. 2024 Sep;
21(1):230.
PMID: 39294742
Background: The IL-6 cytokine family, with its crucial and pleiotropic intracellular signaling pathway STAT3, is a promising target for treating vasoproliferative retinal diseases. Previous research has shown that IL-6 cis-signaling...
6.
Rapp J, Ness J, Liang P, Hug M, Agostini H, Schlunck G, et al.
J Vis Exp
. 2024 Jun;
(207).
PMID: 38884490
Angiogenesis plays a crucial role in both physiological and pathological processes within the body including tumor growth or neovascular eye disease. A detailed understanding of the underlying molecular mechanisms and...
7.
Agostini H, Abreu F, Baumal C, Chang D, Csaky K, Demetriades A, et al.
Graefes Arch Clin Exp Ophthalmol
. 2024 Jun;
262(11):3437-3451.
PMID: 38847896
Intravitreal anti-vascular endothelial growth factor (VEGF) therapy is the standard of care for diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD); however, vision gains and anatomical improvements are...
8.
Poli S, Grohmann C, Wenzel D, Poli K, Tunnerhoff J, Nedelmann M, et al.
Int J Stroke
. 2024 Apr;
19(7):823-829.
PMID: 38591748
Rationale: Meta-analyses of case series of non-arteritic central retinal artery occlusion (CRAO) indicate beneficial effects of intravenous thrombolysis when initiated early after symptom onset. Randomized data are lacking to address...
9.
Hufnagel H, Lahmann C, Agostini H, Lange C, Pauleikhoff L
BMC Ophthalmol
. 2024 Feb;
24(1):92.
PMID: 38424605
Background: Central serous chorioretinopathy (CSC) has frequently been associated with increased stress levels as well as an increased prevalence of other psychiatric conditions. This study used standardized psychometric scores to...
10.
Rapp J, Ness J, Wolf J, Hospach A, Liang P, Hug M, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Jan;
1870(3):167028.
PMID: 38244944
In angiogenesis research, scientists need to carefully select appropriate in vitro models to test their hypotheses to minimize the risk for false negative or false positive study results. In this...